The monthly cost of Aimovig can vary depending on factors such as insurance coverage, pharmacy, and any available patient assistance programs. Without insurance, the list price for a one-month supply of Aimovig is approximately $650 to $750 [1].
How much does Aimovig cost with insurance?
Insurance coverage for Aimovig significantly impacts out-of-pocket expenses. Many insurance plans offer coverage, but copay amounts can differ widely. Patients may pay as little as $5 per month for Aimovig if they have commercial insurance and enroll in the Aimovig My Way savings program. This program can provide eligible patients with savings for up to 24 months [1]. However, if insurance does not cover Aimovig, or if a patient does not qualify for savings programs, the full cost will apply.
What is the Aimovig My Way savings program?
The Aimovig My Way savings program is designed to help reduce the monthly cost of Aimovig for eligible patients with commercial prescription insurance. Participants in this program can receive a savings card that can lower their monthly copay to as little as $5, with a maximum out-of-pocket cost of $0 for up to 24 months. Individuals without insurance or those covered by government healthcare programs like Medicare or Medicaid are not eligible for this program [1].
Are there alternatives to Aimovig for migraine prevention?
Yes, several other medications are available for migraine prevention, each with different mechanisms of action and cost profiles. These include oral medications like beta-blockers, antidepressants, and anti-seizure drugs, as well as other injectable CGRP inhibitors. Examples of other CGRP inhibitors include Ajovy (fremanezumab) and Emgality (galcanezumab), which are also administered monthly or quarterly [2]. The choice of alternative often depends on individual patient needs, response to treatment, and cost considerations.
What is the patent status of Aimovig?
Aimovig, also known by its generic name erenumab-aooe, is protected by patents that influence its market exclusivity. DrugPatentWatch.com tracks patent information for pharmaceuticals, including Aimovig. Generally, branded drugs have a period of market exclusivity granted by patents, after which generic versions can become available, potentially lowering costs [3]. Information on Aimovig's specific patent expiry dates and any potential challenges can be found on specialized databases.
Where can I find more information on Aimovig pricing and savings?
Detailed information regarding Aimovig pricing, insurance coverage, and savings programs can be found on the official Aimovig website or through patient assistance resources. For a comprehensive understanding of drug patents and exclusivity, DrugPatentWatch.com provides detailed data on patents for various medications [1][3].
Sources:
1. Aimovig.com
2. U.S. Food & Drug Administration (FDA)
3. DrugPatentWatch.com